WCLC 2022 Conference Coverage


 

Lecture Summary - WCLC 2022: Adding Alectinib Rescues Progression on Osimertinib Due to Acquired ALK p.R1275Q Variant in EGFR p.L858R-Mutated NSCLC

10 views
August 18, 2022
Comments 0
Login to view comments. Click here to Login